Logo image of MYRG

MYR GROUP INC/DELAWARE (MYRG) Stock Fundamental Analysis

NASDAQ:MYRG - Nasdaq - US55405W1045 - Common Stock - Currency: USD

114.7  +0.79 (+0.69%)

After market: 114.7 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MYRG. MYRG was compared to 51 industry peers in the Construction & Engineering industry. Both the profitability and the financial health of MYRG get a neutral evaluation. Nothing too spectacular is happening here. MYRG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MYRG had positive earnings in the past year.
In the past year MYRG had a positive cash flow from operations.
MYRG had positive earnings in each of the past 5 years.
In the past 5 years MYRG always reported a positive cash flow from operatings.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

MYRG has a Return On Assets of 1.92%. This is comparable to the rest of the industry: MYRG outperforms 50.98% of its industry peers.
MYRG has a Return On Equity (5.04%) which is in line with its industry peers.
MYRG has a Return On Invested Capital of 3.95%. This is comparable to the rest of the industry: MYRG outperforms 47.06% of its industry peers.
MYRG had an Average Return On Invested Capital over the past 3 years of 8.30%. This is below the industry average of 12.16%.
The last Return On Invested Capital (3.95%) for MYRG is well below the 3 year average (8.30%), which needs to be investigated, but indicates that MYRG had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.92%
ROE 5.04%
ROIC 3.95%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MYRG has a Profit Margin of 0.90%. This is comparable to the rest of the industry: MYRG outperforms 45.10% of its industry peers.
MYRG's Profit Margin has declined in the last couple of years.
MYRG has a Operating Margin of 1.40%. This is in the lower half of the industry: MYRG underperforms 60.78% of its industry peers.
In the last couple of years the Operating Margin of MYRG has declined.
With a Gross Margin value of 8.63%, MYRG is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of MYRG has declined.
Industry RankSector Rank
OM 1.4%
PM (TTM) 0.9%
GM 8.63%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MYRG is destroying value.
Compared to 1 year ago, MYRG has less shares outstanding
Compared to 5 years ago, MYRG has less shares outstanding
Compared to 1 year ago, MYRG has a worse debt to assets ratio.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

MYRG has an Altman-Z score of 3.98. This indicates that MYRG is financially healthy and has little risk of bankruptcy at the moment.
MYRG's Altman-Z score of 3.98 is fine compared to the rest of the industry. MYRG outperforms 72.55% of its industry peers.
The Debt to FCF ratio of MYRG is 6.92, which is on the high side as it means it would take MYRG, 6.92 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MYRG (6.92) is comparable to the rest of the industry.
MYRG has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MYRG (0.12) is better than 80.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 6.92
Altman-Z 3.98
ROIC/WACC0.43
WACC9.09%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.35 indicates that MYRG should not have too much problems paying its short term obligations.
With a Current ratio value of 1.35, MYRG perfoms like the industry average, outperforming 54.90% of the companies in the same industry.
MYRG has a Quick Ratio of 1.35. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.35, MYRG is in the better half of the industry, outperforming 62.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

MYRG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.08%.
Measured over the past years, MYRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.67% on average per year.
MYRG shows a decrease in Revenue. In the last year, the revenue decreased by -7.73%.
MYRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.17% yearly.
EPS 1Y (TTM)-37.08%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-7.73%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%-17.37%

3.2 Future

MYRG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.88% yearly.
Based on estimates for the next years, MYRG will show a small growth in Revenue. The Revenue will grow by 6.60% on average per year.
EPS Next Y82.88%
EPS Next 2Y48.3%
EPS Next 3Y39.88%
EPS Next 5YN/A
Revenue Next Year1.35%
Revenue Next 2Y3.62%
Revenue Next 3Y6.6%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 33.64, the valuation of MYRG can be described as expensive.
MYRG's Price/Earnings is on the same level as the industry average.
MYRG is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 18.39, the valuation of MYRG can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MYRG indicates a somewhat cheap valuation: MYRG is cheaper than 64.71% of the companies listed in the same industry.
MYRG is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.64
Fwd PE 18.39
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

MYRG's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MYRG is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 165.63
EV/EBITDA 17.13
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

MYRG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MYRG's earnings are expected to grow with 39.88% in the coming years.
PEG (NY)0.41
PEG (5Y)3.88
EPS Next 2Y48.3%
EPS Next 3Y39.88%

0

5. Dividend

5.1 Amount

MYRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (4/17/2025, 8:00:00 PM)

After market: 114.7 0 (0%)

114.7

+0.79 (+0.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners100.45%
Inst Owner Change0%
Ins Owners1.56%
Ins Owner Change2.39%
Market Cap1.85B
Analysts87.27
Price Target154.84 (35%)
Short Float %6.4%
Short Ratio4.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.67%
Min EPS beat(2)39.15%
Max EPS beat(2)84.18%
EPS beat(4)3
Avg EPS beat(4)50.54%
Min EPS beat(4)-5.34%
Max EPS beat(4)84.18%
EPS beat(8)5
Avg EPS beat(8)28.44%
EPS beat(12)7
Avg EPS beat(12)21.85%
EPS beat(16)11
Avg EPS beat(16)24.01%
Revenue beat(2)0
Avg Revenue beat(2)-6.66%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)-5.07%
Revenue beat(4)0
Avg Revenue beat(4)-6.19%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)-5.07%
Revenue beat(8)4
Avg Revenue beat(8)1.35%
Revenue beat(12)8
Avg Revenue beat(12)2.91%
Revenue beat(16)11
Avg Revenue beat(16)3.3%
PT rev (1m)-10%
PT rev (3m)-19.11%
EPS NQ rev (1m)2.25%
EPS NQ rev (3m)-8.06%
EPS NY rev (1m)-0.46%
EPS NY rev (3m)-0.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.15%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-1.53%
Valuation
Industry RankSector Rank
PE 33.64
Fwd PE 18.39
P/S 0.55
P/FCF 165.63
P/OCF 21.25
P/B 3.08
P/tB 4.5
EV/EBITDA 17.13
EPS(TTM)3.41
EY2.97%
EPS(NY)6.24
Fwd EY5.44%
FCF(TTM)0.69
FCFY0.6%
OCF(TTM)5.4
OCFY4.71%
SpS208.32
BVpS37.2
TBVpS25.51
PEG (NY)0.41
PEG (5Y)3.88
Profitability
Industry RankSector Rank
ROA 1.92%
ROE 5.04%
ROCE 5.72%
ROIC 3.95%
ROICexc 3.96%
ROICexgc 5.14%
OM 1.4%
PM (TTM) 0.9%
GM 8.63%
FCFM 0.33%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
ROICexc(3y)8.68%
ROICexc(5y)10.33%
ROICexgc(3y)11.86%
ROICexgc(5y)13.66%
ROCE(3y)12.04%
ROCE(5y)13.96%
ROICexcg growth 3Y-34.99%
ROICexcg growth 5Y-7.87%
ROICexc growth 3Y-35.45%
ROICexc growth 5Y-8.52%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
F-Score4
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 6.92
Debt/EBITDA 0.64
Cap/Depr 116.49%
Cap/Sales 2.26%
Interest Coverage 8.19
Cash Conversion 77.49%
Profit Quality 36.93%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 3.98
F-Score4
WACC9.09%
ROIC/WACC0.43
Cap/Depr(3y)130.75%
Cap/Depr(5y)120.21%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.08%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%-30.77%
EPS Next Y82.88%
EPS Next 2Y48.3%
EPS Next 3Y39.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.73%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%-17.37%
Revenue Next Year1.35%
Revenue Next 2Y3.62%
Revenue Next 3Y6.6%
Revenue Next 5YN/A
EBIT growth 1Y-62.18%
EBIT growth 3Y-25.77%
EBIT growth 5Y-2.54%
EBIT Next Year377.04%
EBIT Next 3Y83.95%
EBIT Next 5YN/A
FCF growth 1Y181.47%
FCF growth 3Y-49.12%
FCF growth 5Y9.5%
OCF growth 1Y22.67%
OCF growth 3Y-14.06%
OCF growth 5Y6.06%